Nasdaq-listed Solana treasury company Artelo Biosciences announced the issuance of 640,924 common shares to the public at a price of $4.40 per share, raising a total of approximately $3 million. Artelo Biosciences is a clinical pharmaceutical company that has previously announced the official launch of a Solana-based digital asset treasury strategy and will invest part of its capital in the purchase of SOL tokens. As of now, it holds 45,883 SOL.
纳斯达克上市的Solana财库公司Artelo Biosciences宣布以每股4.40美元的价格向公众发行640,924股普通股,募集总计约300万美元资金,Artelo Biosciences是一家临床制药公司,此前已宣布正式启动基于Solana的数字资产财库战略并将部分资本投入购买SOL代币,截至目前持有45883枚SOL。